Stock Analysis on Net

Thermo Fisher Scientific Inc. (NYSE:TMO)

Statement of Comprehensive Income 

Thermo Fisher Scientific Inc., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income 5,955 6,960 7,728 6,377 3,698
Currency translation adjustment, net of tax (69) (822) 373 (118) (106)
Reclassification adjustment for (gains) losses included in net income 30
Currency translation adjustment (69) (822) 373 (118) (76)
Unrealized gains (losses) on hedging instruments, net of tax (65) (38)
Reclassification adjustment for (gains) losses included in net income, net of tax 5 2 56 45 19
Unrealized gains (losses) on hedging instruments 5 2 56 (20) (19)
Pension and other postretirement benefit liability adjustments arising during the period, net of tax (69) 38 36 (8) (93)
Amortization of net loss and prior service benefit included in net periodic pension cost, net of tax 5 13 18 8
Pension and other postretirement benefit liability adjustments (69) 43 49 10 (85)
Other comprehensive income (loss) (133) (777) 478 (128) (180)
Comprehensive income 5,822 6,183 8,206 6,249 3,518
Comprehensive (income) loss attributable to noncontrolling interests and redeemable noncontrolling interest 48 (3) (2) (2) (3)
Comprehensive income attributable to Thermo Fisher Scientific Inc. 5,870 6,180 8,204 6,247 3,515

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Comprehensive income item Description The company
Net income attributable to Thermo Fisher Scientific Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Thermo Fisher Scientific Inc. net income attributable to Thermo Fisher Scientific Inc. decreased from 2021 to 2022 and from 2022 to 2023.
Comprehensive income attributable to Thermo Fisher Scientific Inc. Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Thermo Fisher Scientific Inc. comprehensive income attributable to Thermo Fisher Scientific Inc. decreased from 2021 to 2022 and from 2022 to 2023.